Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Wei, Pengfei ^a   Cai, Zelang ^a   Hua, Jinwen ^a   Yu, Weijia ^a   Chen, Jiajie ^a   Kang, Kang ^a   Qiu, Congling ^a   Ye, Lanlan ^a   Hu, Jiayun ^a   Ji, Kunmei ^a  

^a SHENZHEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

AFRICA; AVIAN INFLUENZA; BIOMEDICINE; BIOTECHNOLOGY; CHINA; CONTROL SYSTEM; CORONAVIRIDAE; DRUG MANUFACTURE; EBOLA HEMORRHAGIC FEVER; EMERGENCY HEALTH SERVICE; EPIDEMIC; FUNDING; FUTUROLOGY; GOVERNMENT REGULATION; HUMAN; INDUSTRIALIZATION; INFECTION PREVENTION; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N9); LAW ENFORCEMENT; PUBLIC HEALTH SERVICE; REINFORCEMENT; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; ADOLESCENT; ADULT; AGED; CHILD; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; EPIDEMICS; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MORTALITY; NEWBORN; PRESCHOOL CHILD; PREVALENCE; PROCEDURES; RISK FACTOR; STANDARDS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; EPIDEMICS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SEVERE ACUTE RESPIRATORY SYNDROME; SURVIVAL RATE; YOUNG ADULT;

EID: 84982793442     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/5717108     Document Type: Review

References (47)

1. R. M. Anderson, C. Fraser, A. C. Ghani et al., "Epidemiology, transmission dynamics and control of SARS: The 2002-2003 epidemic, " Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences, vol. 359, no. 1447, pp. 1091-1105, 2004.
2. Y. Guan, B. J. Zheng, Y. Q. He et al., "Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China, " Science, vol. 302, no. 5643, pp. 276-278, 2003.
3. World Health Organization, Cumulative Number of Reported Probable Cases of SARS 2015, http://www.who. int/csr/sars/ country/2003 07 11/en/index. html.
4. K. S. Li, Y. Guan, J. Wang et al., "Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in easternAsia, " Nature, vol. 430, no. 6996, pp. 209-213, 2004.
5. World Health Organization, Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO 2015, http://www.who. int/influenza/human animal interface/ H5N1 cumulative table archives/en/.
6. WHO, China-WHO Joint Mission on Human Infection with Avian Influenza A (H7N9) Virus, World Health Organization, Geneva, Switzerland, 2013.
7. World Health Organization, Influenza at the Human-Animal Interface, 2015, http://www.who. int/influenza/human animal interface/HAI Risk Assessment/en/.
8. W. Zhang, J. G. Wan, K. J. Qian et al., "Clinical characteristics of human infection with a novel avian-origin influenza A(H10N8) virus, " Chinese Medical Journal, vol. 127, no. 18, pp. 3238-3242, 2014.
9. World Health Organization, Human infection with avian influenza A(H5N6) virus-China. 2014, http://www.who. int/csr/ don/28-december-2014-avian-influenza/en/.
10. R. Stone, "China first to vaccinate against novel H1N1 virus, " Science, vol. 325, no. 5947, pp. 1482-1483, 2009.
11. N. Zhong and G. Zeng, "What we have learnt from SARS epidemics in China, " British Medical Journal, vol. 333, no. 7564, pp. 389-391, 2006.
12. J. S. M. Peiris, S. T. Lai, L. L. M. Poon et al., "Coronavirus as a possible cause of severe acute respiratory syndrome, " The Lancet, vol. 361, no. 9366, pp. 1319-1325, 2003.
13. C. Drosten, S. Gunther, W. Preiser et al., "Identification of a novel coronavirus in patients with severe acute respiratory syndrome, "The New England Journal of Medicine, vol. 348, no. 20, pp. 1967-1976, 2003.
14. T. G. Ksiazek, D. Erdman, C. S. Goldsmith et al., "A novel coronavirus associatedwith severe acute respiratory syndrome, " The New England Journal ofMedicine, vol. 348, no. 20, pp. 1953-1966, 2003.
15. M. A. Marra, S. J. Jones, C. R. Astell et al., "The Genome sequence of the SARS-associated coronavirus, " Science, vol. 300, no. 5624, pp. 1399-1404, 2003.
16. World Health Organization, Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS), 2003, http://www.who. int/csr/sars/en/WHOconsensus. pdf.
17. G. Z. Tian and Z. C. Gao, "Clinical status and its associated early warning per emerging infectious respiratory disease in China, " Chinese Medical Journal, vol. 127, no. 17, pp. 3043-3045, 2014.
18. China TCPsGotPsRo, The Regulation on Public Health Emergency 2003, http://www.gov. cn/zwgk/2005-05/20/content 145. htm.
19. China TCPsGotPsRo, Measures for the Administration of Information Reporting on the Monitoring of Public Health Emergencies and Epidemic Situation of Infectious Diseases, 2003.
20. China TCPsGotPsRo, The Law on the Prevention and Treatment of Infectious Diseases, 2004, http://www.gov. cn/banshi/2005-05/25/content 971. htm.
21. NHFPC, A Technical Guide for Avian Flu Prevention and Control, 2004, http://www.nhfpc. gov. cn/zhuzhan/zcjd/201304/ 419f17bed4294f3cafe96e0989a0496d. shtml.
22. China TCPsGotPsRo, Law on Animal Disease Prevention, 2007, http://www.gov. cn/ziliao/flfg/2007-08/31/content 732590. htm.
23. nhfpc, "Guide on prevention of human infection of swine flu 2009, " http://www.nhfpc. gov. cn/yjb/s3577/200904/77409e8ed-2d64873adc7a9559ab90c2f. shtml.
24. NHFPC, Guide on Preventing NosocomialH7N9-Infection, 2013, http://www.nhfpc. gov. cn/yjb/bmdt/201304/78b2497cfd1c4379-82fd2ff3ea7b43bb. shtml.
25. XinhuaNet, Confirmation of the First H1N1 Case in China, 2009, http: //news. xinhuanet. com/newscenter/2009-05/11/content 11351952. htm.
26. NHFPC. 3 cases of human-infected H7N9 influenza virus in Shanghai and Anhui 2013, http://www.nhfpc. gov. cn/yjb/ s3578/201303/1d2509cd264c4e36af1dc5505d4ba577. shtml.
27. NHFPC, Report of State Counsel on Infectious Diseases Control and Laws Enforcement, 2013, http://www.moh. gov. cn/jkj/s3578/ 201308/e2f9490aa4d742bdb978e4a277e095d9. shtml.
28. R. Gao, B. Cao, Y. Hu et al., "Human infection with a novel avian-origin influenza A (H7N9) virus, " The New England Journal of Medicine, vol. 368, no. 20, pp. 1888-1897, 2013.
29. H. Chen, H. Yuan, R. Gao et al., "Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: A descriptive study, " The Lancet, vol. 383, no. 9918, pp. 714-721, 2014.
30. WHO, Human Infection with Avian Influenza A(H5N6) Virus-China, 2015, http://www.who. int/csr/don/12-february-2015-avian-influenza/en/.
31. H. Rohde, J. Qin, Y. Cui et al., "Open-source genomic analysis of Shiga-toxin-producing E. coli O104: H4, " The New England Journal of Medicine, vol. 365, no. 8, pp. 718-724, 2011.
32. W. Li, Z. Shi, M. Yu et al., "Bats are natural reservoirs of SARSlike coronaviruses, " Science, vol. 310, no. 5748, pp. 676-679, 2005.
33. T. T.-Y. Lam, J. Wang, Y. Shen et al., "The genesis and source of the H7N9 influenza viruses causing human infections in China, " Nature, vol. 502, no. 7470, pp. 241-244, 2013.
34. CFaD Administration, China's National Vaccine Regulatory SystemPassed theAssessment ofWHO, 2011, http://www.sda. gov. cn/WS01/CL0051/59074. html.
35. Administration CFAD, Datasearch 2015, http: //app1. sfda. gov. cn/datasearch/face3/dir. html.
36. H. Yang, M. Yang, Y. Ding et al., "The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor, " Proceedings of theNational Academy of Sciences of the United States of America, vol. 100, no. 23, pp. 13190-13195, 2003.
37. T. Lin, G. Wang, A. Li et al., "The hemagglutinin structure of an avian H1N1 influenza A virus, " Virology, vol. 392, no. 1, pp. 73-81, 2009.
38. X. He, J. Zhou, M. Bartlam et al., "Crystal structure of the polymerase PAC-PB1N complex from an avian influenza H5N1 virus, " Nature, vol. 454, no. 7208, pp. 1123-1126, 2008.
39. Y. Wu, Y. Bi, C. J. Vavricka et al., "Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses, " Cell Research, vol. 23, no. 12, pp. 1347-1355, 2013.
40. C. Wang, B. Cao, Q. Q. Liu et al., "Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: A randomized trial, " Annals of Internal Medicine, vol. 155, no. 4, pp. 217-225, 2011.
41. China NHaFPCotPsRo, "State Council's report on infectious diseases control and prevention 2013, " 2015, http://www.moh. gov. cn/jkj/s3578/201308/e2f9490aa4d742bdb978e4a277e095d9. shtml.
42. World Health Organization, Ebola Current Situation, 2015, http: //apps. who. int/ebola/en/current-situation/ebola-situationreport-10-june-2015.
43. NHFPC, "InternationalWorkshop on Ebola virus 2015, " http: // www. nhfpc. gov. cn/gjhzs/s3586/201503/beec6959564c493eaa9-cf5b852e32608. shtml.
44. CFDA, Datasearch 2014, http: //app1. sfda. gov. cn/datasearch/ face3/dir. html.
45. F.-C. Zhu, L.-H. Hou, J.-X. Li et al., "Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: Preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial, " The Lancet, vol. 385, no. 9984, pp. 2272-2279, 2015.
46. China TSCoTPsRo, Chinese drug MIL-77 used to cure British Ebola patient 2015, http: //english. gov. cn/news/top news/2015/ 04/01/content 281475081160890. htm.
47. J. Wu, L. Yi, L. Zou et al., "Imported case of MERS-CoV infection identified in China, May 2015: detection and lesson learned, " Eurosurveillance, vol. 20, no. 24, article 1, 2015.